Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > antidote market
Get a free sample of Antidote Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Antidote Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Antidote market size was valued at around USD 2.3 billion in 2023 and is estimated to grow at 8.1% CAGR from 2024 to 2032. An antidote is a substance that counteracts a form of poisoning. Specifically, it neutralizes or inhibits the harmful effects of a toxin or poison in the body.
Antidotes can work through various mechanisms such as binding to the toxin to neutralize it, enhancing its elimination from the body, or counteracting its toxic effects on a cellular or systemic level. They are crucial in medical emergencies involving toxic substances, including drugs, chemicals, and biological agents.
The increasing incidence of overdoses is a significant driver for the antidote market. For instance, according to the World Health Organization (WHO), there were 106,699 drug overdose deaths in the U.S. in 2021. The age-adjusted rate of these deaths rose by 14%, from 28.3 per 100,000 in 2020 to 32.4 per 100,000 in 2021. This underscores the urgent need for effective antidotes to counteract the growing number of drug overdoses and save lives. Consequently, the demand for antidotes such as naloxone for opioid overdoses, is expected to rise, propelling the growth of the market.
Moreover, growing awareness and training programs, technological advancements, and increasing research and development activities, are the stimulating factors fostering the growth of the market.
U.S. antidote industry size is likely to witness 7.9% CAGR during 2024-2032, owing to the presence of highly developed healthcare infrastructure with a vast network of hospitals, clinics, and medical facilities.
Chemical antidote industry is estimated to account for USD 1.9 billion by the end of 2032, as they act quickly, which is vital in emergency situations.
The antidote market size was valued at USD 2.3 billion in 2023 and is estimated to grow at 8.1% CAGR from 2024 to 2032, driven by the increasing incidence of overdoses.
Alvogen , Aurobindo Pharma Limited, Akorn Operating Company LLC, Baxter International, Inc, Daiichi Sanko Group, Dr. Reddy